
Join to View Full Profile
- 8081 Innovation Park Dr765Fairfax, VA 22031 
- Phone+1 571-472-1717 
- Fax+1 571-472-1718 
Dr. Viola is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
 Oregon Health & Science University (OHSU Health)Fellowship, Pediatric Hematology/Oncology, 2012 - 2015 Oregon Health & Science University (OHSU Health)Fellowship, Pediatric Hematology/Oncology, 2012 - 2015
 Naval Medical Center (San Diego)Residency, Pediatrics, 2006 - 2009 Naval Medical Center (San Diego)Residency, Pediatrics, 2006 - 2009
 Eastern Virginia Medical SchoolClass of 2006 Eastern Virginia Medical SchoolClass of 2006
Certifications & Licensure
 CA State Medical License 2016 - Present CA State Medical License 2016 - Present
 OR State Medical License 2014 - Present OR State Medical License 2014 - Present
 TN State Medical License 2021 - 2026 TN State Medical License 2021 - 2026
 VA State Medical License 2008 - 2026 VA State Medical License 2008 - 2026
 AZ State Medical License 2016 - 2022 AZ State Medical License 2016 - 2022
 KS State Medical License 2019 - 2021 KS State Medical License 2019 - 2021
 American Board of Pediatrics Pediatrics American Board of Pediatrics Pediatrics
 American Board of Pediatrics Pediatric Hematology-Oncology American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- Molecular Risk Markers Define Risk of Relapse in Myeloid Leukemia of Down syndrome Beyond Measurable Residual Disease.Jason N Berman, Anupam Verma, Shelton A Viola, Todd Alonzo, Yi-Cheng Wang
 Blood Advances. 2025-10-22
- 3 citationsAffirming Hormone Treatment for a Transgender Adolescent After a Venous Thromboembolic Event.Scott W Penney, Jenny H Jung, Aaron J Ballantyne, Dina S Parekh, David A Klein
 Journal of Pediatric Hematology/oncology. 2022-07-01
- 17 citationsHigh-dose AraC is Essential for the Treatment of ML-DS Independent of Post-Induction MRD: Results of COG AAML1531.Johann Hitzler, Todd A. Alonzo, Robert B. Gerbing, Amy Beckman, Betsy A. Hirsch
 Blood. 2021-07-28
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









